Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous serum versus artificial tears after epithelium-off corneal collagen cross-linking
IRCT20161218031450N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of autologous serum tears and artificial tears in keratoconus (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Pain intensity and Epithelium closure time. Started Sep 2023; status: completed.
02
Drugs
autologous serum tearsartificial tears
03
Conditions
keratoconus
Beyond the preview
Go deeper on IRCT20161218031450N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161218031450N6.